购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Endogenous Metabolite
    (1)
  • Estrogen/progestogen Receptor
    (1)
  • Progesterone Receptor
    (1)
  • Prostaglandin Receptor
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (3)
  • 5日内发货
    (5)
  • 35日内发货
    (1)
  • 8-10周
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "trimester"的结果
筛选
搜索结果
TargetMol产品目录中 "

trimester

"的结果
  • 抑制剂&激动剂
    4
    TargetMol | Inhibitors_Agonists
  • 重组蛋白
    6
    TargetMol | Recombinant_Protein
  • 天然产物
    1
    TargetMol | Natural_Products
  • Carboprost
    卡前列素, 15-Methyl-PGF2α, 15(S)-15-Methyl Prostaglandin F2α
    T2228535700-23-3
    Carboprost (15(S)-15-Methyl Prostaglandin F2α) 是一种前列腺素 F2α 的代谢稳定的合成类似物。它能够刺激子宫收缩并引起流产,可用于子宫收缩乏力引起的产后出血,以及在妊娠中期终止妊娠。
    • ¥ 338
    In stock
    规格
    数量
  • 17α-Hydroxyprogesterone
    羟孕酮, Hydroxyprogesterone, 17α-羟孕酮, 17-OHP, 17-Hydroxyprogesterone
    T142968-96-2
    17α-Hydroxyprogesterone (17-OHP) 是一种内源性孕激素,其他类固醇激素(包括糖皮质激素,雌激素,和雄激素)生物合成的化学中间体。
    • ¥ 298
    In stock
    规格
    数量
  • 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2
    9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2
    T3682961263-35-2
    9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2 (Meteneprost) is a potent analog of prostaglandin E2 with an extended half-life in vivo. In combination with various other prostaglandin derivatives, it results in the termination of first trimester pregnancy in monkeys. A single intramuscular injection containing 0.5 mg of meteneprost and 7.5 mg of 17-phenyl trinor PGF1α is very effective in terminating early pregnancy. This prostaglandin mixture is ineffective on monkeys in their third trimester of pregnancy. Meteneprost, when compared to PGE2 and PGF1α, in monkey and rat, does not result in unwanted side effects such as fever or gastrointestinal problems.
    • 待估
    35日内发货
    规格
    数量
  • 13,14-dihydro-15-keto Prostaglandin E2
    13,14-dihydro-15-keto PGE2
    T84586363-23-5
    13,14-dihydro-15-keto Prostaglandin E2 (13,14-dihydro-15-keto PGE2) serves as the predominant metabolite of PGE2 in plasma, created through a 15-keto PGE2 intermediate by the action of 15-oxo-PG Δ13 reductase. Unlike its precursor PGE2, this compound exhibits poor binding affinity towards EP2 and EP4 PGE2 receptors (Ki values of 12 and 57 µM, respectively) in CHO cells and fails to stimulate adenylate cyclase activity therein (EC50s >18 and >38 µM, respectively). Concentrations of 13,14-dihydro-15-keto PGE2 are notably higher in the plasma of pregnant women during their third trimester and at labor and delivery stages, whereas its levels are found to be reduced in the tumor tissues of patients with non-small cell lung cancer (NSCLC) compared to adjacent healthy tissue.
    • 待询
    8-10周
    规格
    数量